Adverum Biotechnologies, Inc.
ADVM
$3.08
$0.051.65%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -74.46% | -57.02% | 30.21% | 30.88% | 22.89% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -28.56% | 10.07% | -10.21% | 4.33% | -1.74% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -73.03% | -55.07% | 27.76% | 29.28% | 21.93% |
|
|||||
Total Current Assets | -73.03% | -55.07% | 27.76% | 29.28% | 21.93% |
Net Property, Plant & Equipment | -31.02% | -31.75% | -9.18% | -7.83% | -28.83% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -65.86% | 9.27% | 3.62% | 164.92% | 155.20% |
Total Assets | -62.10% | -48.60% | 15.45% | 19.11% | 5.13% |
|
|||||
Total Accounts Payable | 140.65% | -4.11% | -16.19% | -2.76% | 39.14% |
Total Accrued Expenses | 99.08% | 85.46% | 23.28% | -6.43% | -41.14% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -30.38% | -31.10% | 3.51% | 3.26% | -58.36% |
Total Finance Division Other Current Liabilities | 30.42% | -6.97% | 36.20% | -30.48% | -65.68% |
Total Other Current Liabilities | 30.42% | -6.97% | 36.20% | -30.48% | -65.68% |
Total Current Liabilities | 39.60% | 16.45% | 14.60% | -4.16% | -49.55% |
|
|||||
Total Current Liabilities | 39.60% | 16.45% | 14.60% | -4.16% | -49.55% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 34.03% | 34.31% | 25.48% | -3.98% | -3.72% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 35.70% | 30.04% | 23.24% | -4.04% | -22.22% |
|
|||||
Common Stock & APIC | 1.04% | 1.19% | 13.39% | 13.53% | 13.74% |
Retained Earnings | -20.78% | -17.93% | -13.99% | -10.50% | -11.57% |
Treasury Stock & Other | 14.10% | 14.07% | 13.95% | 51.45% | 13.37% |
Total Common Equity | -112.03% | -85.51% | 5.19% | 40.31% | 28.11% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -112.03% | -85.51% | 5.19% | 40.31% | 28.11% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -112.03% | -85.51% | 5.19% | 40.31% | 28.11% |
|